Evidence map›Paper›PMID 20513426›Full record

ArticleMolecular cell2010

Negative regulation of Vps34 by Cdk mediated phosphorylation.

Tsuyoshi Furuya, Minsu Kim, Marta Lipinski, Juying Li, Dohoon Kim, Tao Lu, Yong Shen, Lucia Rameh, Bruce Yankner, Li-Huei Tsai and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
9.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it, 170 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The role of lipid metabolism in cognitive impairment.Arquivos de neuro-psiquiatria · 2025
    Review
  12. Review
  13. Review
  14. Physiological functions of ULK1/2.Journal of molecular biology · 2024
    Review
  15. bioRxiv : the preprint server for biology · 2024
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Tsuyoshi FuruyaDepartment of Cell Biology, Harvard Medical School, Boston, MA 02115, USA.
Minsu Kim
Marta Lipinski
Juying Li
Dohoon Kim
Tao Lu
Yong Shen
Lucia Rameh
Bruce Yankner
Li-Huei Tsai
Junying Yuan
Harvard University · USMassachusetts Institute of Technology · USBanner Sun Health Research Institute · USBoston Biomedical Research Institute · US

Funding

THE ROLE OF Cdk5 IN THE DNA DAMAGE RESPONCE DURING AGING AND NEURODEGENERATIONP01AG027916 · NIA · HARVARD MEDICAL SCHOOL · PI SINCLAIR, DAVID A. · 2006 to 2010
$7.7M
Mechanism and Regulation of Caspase-11R37AG012859 · NIA · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI YUAN, JUNYING · 2002 to 2011
$4.5M
Modeling the Aging EpigenomeDP1AG044161 · NIA · HARVARD MEDICAL SCHOOL · PI YANKNER, BRUCE A · 2012 to 2014
$2.5M
NIA NIH HHS DP1 AG044161NIA NIH HHS P01 AG027916NIA NIH HHS R37 AG 012859NIA NIH HHS R37 AG012859
6 · The paper itself

Abstract

Vacuolar protein sorting 34 (Vps34) complexes, the class III PtdIns3 kinase, specifically phosphorylate the D3 position of PtdIns to produce PtdIns3P. Vps34 is involved in the control of multiple key intracellular membrane trafficking pathways including endocytic sorting and autophagy. In mammalian cells, Vps34 interacts with Beclin 1, an ortholog of Atg6 in yeast, to regulate the production of PtdIns3P and autophagy. We show that Vps34 is phosphorylated on Thr159 by Cdk1, which negatively regulates its interaction with Beclin 1 during mitosis. Cdk5/p25, a neuronal Cdk shown to play a role in Alzheimer's disease, can also phosphorylate Thr159 of Vps34. Phosphorylation of Vps34 on Thr159 inhibits its interaction with Beclin 1. We propose that phosphorylation of Thr159 in Vps34 is a key regulatory mechanism that controls the class III PtdIns3 kinase activity in cell-cycle progression, development, and human diseases including neurodegeneration and cancers.

Indexed as

Cyclin-Dependent KinasesHeLa CellsHumansMitosisPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase InhibitorsPhosphorylationCyclin-Dependent KinasesPhosphatidylinositol 3-KinasesPhosphoinositide-3 Kinase Inhibitors

Identifiers

PMID20513426
PMCPMC2888511
OpenAlexW2081431643

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.